Noble Life Sciences in partnership with NorthEast BioLab is hosting a webinar. Overview: The need for expedited drug development and efficient capital allocation has placed a justified emphasis on early in vivo testing for pharmacology and disease modulation. In this webinar, we would share actionable insights from our 100+ years of collective experience managing drug discovery, pharmacokinetics (PK), and biomarker testing studies.    Agenda: Drug discovery screening process from target selectivity to potency in preclinical disease models In vivo proof-of-concept PK and Biomarker testing towards clinical efficacy based on drug exposure and biological response In vitro ADME (protein binding, [...]

Noble Life Sciences Hosts Panel Discussion “Vaccinology in the 21st Century: Engineering an Effective Vaccine Platform” Featuring: Andrew Lees, PhD, Scientific Director, Fina BioSolutions Peter Pushko, PhD, Chief Scientific Officer, Medigen Spencer Stonier, PhD, Director Vaccines Pipeline, Emergent BioSolutions Todd Parsley, PhD, Director Infectious Diseases, Noble Life Sciences (Moderator) Register Now Background: With much of the world’s focus on the development of SARS-CoV-2 vaccine, we are bringing an expert panel together to discuss the challenges and strategies for engineering an effective and safe vaccine. The panelists will share their expertise in vaccine development to discuss topically relevant aspects of [...]

Noble Life Sciences Hosts Webinar “Live animal imaging in Oncology preclinical drug development” Speaker: Dr. Stephen Horrigan, Chief Scientific Officer, Noble Life Sciences Register Now Small animal optical imaging provides oncology researchers the ability to perform non-invasive longitudinal monitoring of disease progression, detection of metastasis and micro metastasis, and to accurately quantify tumor burden in a wide variety of animal models. This can be used to effectively monitor and quantitate responses to therapeutics and develop translational biomarkers that can be used throughout your drug development program. The sensitivity, versatility and non-invasive nature of combined luminescent and fluorescent imaging also [...]